论文部分内容阅读
子宫内膜增生被认为是由于长期的、无拮抗的内源性或外源性雌激素刺激所致。使增生的内膜退缩且恢复至正常以预防腺癌发生是保守治疗的目的。 本研究评价患不同类型子宫内膜增生的患者经促性腺激素释放激素激动剂(GnRH-a)——曲普瑞林(Triptorelin)治疗6个月后内膜退缩至正常的结局。 56例患者参加本研究,平均年龄46.2±5.6岁(30～54岁)。所有人均有不正常阴道
Endometrial hyperplasia is thought to be due to long-term, non-antagonistic endogenous or exogenous estrogen stimulation. The proliferation of endometrial degeneration and return to normal to prevent the occurrence of adenocarcinoma is the purpose of conservative treatment. This study evaluated the intimal regression to normal outcome after 6 months of treatment with gnRH-a-Triptorelin in patients with different types of endometrial hyperplasia. 56 patients participated in this study, with an average age of 46.2 ± 5.6 years (30 to 54 years). Everyone has abnormal vagina